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ABSTRACT The human papillomavirus (HPV) replication cycle is tightly linked to ep-
ithelial cell differentiation. To examine HPV-associated changes in the keratinocyte
transcriptome, RNAs isolated from undifferentiated and differentiated cell popula-
tions of normal, spontaneously immortalized keratinocytes (NIKS) and NIKS stably
transfected with HPV16 episomal genomes (NIKS16) were compared using next-
generation sequencing (RNA-Seq). HPV16 infection altered expression of 2,862 cel-
lular genes. Next, to elucidate the role of keratinocyte gene expression in late
events during the viral life cycle, RNA-Seq was carried out on triplicate differenti-
ated populations of NIKS (uninfected) and NIKS16 (infected). Of the top 966
genes altered (log2  1.8, 3.5-fold change), 670 genes were downregulated
and 296 genes were upregulated. HPV downregulated many genes involved in
epithelial barrier function, which involves structural resistance to the environ-
ment and immunity to infectious agents. For example, HPV infection repressed
expression of the differentiated keratinocyte-speciﬁc pattern recognition receptor
TLR7, the Langerhans cell chemoattractant CCL20, and proinﬂammatory cytokines in-
terleukin 1 (IL-1) and IL-1. However, the type I interferon regulator IRF1, kappa
interferon (IFN-), and viral restriction factors (IFIT1, -2, -3, and -5, OASL, CD74, and
RTP4) were upregulated. HPV infection abrogated gene expression associated with
the physical epithelial barrier, including keratinocyte cytoskeleton, intercellular junc-
tions, and cell adhesion. Quantitative PCR (qRT-PCR) and Western blotting conﬁrmed
changes in expression of seven of the most signiﬁcantly altered mRNAs. Expression
of three genes showed statistically signiﬁcant changes during cervical disease pro-
gression in clinical samples. Taken together, the data indicate that HPV infection ma-
nipulates the differentiating keratinocyte transcriptome to create an environment
conducive to productive viral replication and egress.
IMPORTANCE HPV genome ampliﬁcation and capsid formation take place in differ-
entiated keratinocytes. The viral life cycle is intimately associated with host cell dif-
ferentiation. Deep sequencing (RNA-Seq) of RNA from undifferentiated and differen-
tiated uninfected and HPV16-positive keratinocytes showed that almost 3,000 genes
were differentially expressed in keratinocytes due to HPV16 infection. Strikingly, the
epithelial barrier function of differentiated keratinocytes, comprising keratinocyte im-
mune function and cellular structure, was found to be disrupted. These data provide
new insights into the virus-host interaction that is crucial for the production of in-
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fectious virus and reveal that HPV infection remodels keratinocytes for completion of
the virus replication cycle.
KEYWORDS human papillomavirus 16, epithelial differentiation, keratinocyte
transcriptome, cervical disease, epithelial cells
Human papillomaviruses (HPVs) infect keratinocytes, causing mainly benign lesionsor warts (1). Infection is usually transient and is cleared by the immune system (2).
However, persistent infection with “high-risk” HPV genotypes (HR-HPV) can cause
tumor progression to cervical (3), other anogenital (anal, penile, vulvar, and vaginal) (4),
and oropharyngeal (5) cancers. In the case of the cervix, cervical intraepithelial neo-
plasia (CIN) generally precedes cervical cancer progression (6). CIN1 is thought to
represent a transient HPV infection, while CIN3 represents clinically signiﬁcant, persis-
tent HPV infection that may, if left untreated, progress to cervical cancer (7).
The pathway of epithelial cell differentiation, from basal to granular layer, is tightly
controlled by complex patterns of keratinocyte gene expression (8). The HPV infectious
life cycle is tightly linked to epithelial differentiation. HPV infects basal epithelial cells,
where it begins to express its genome. The viral replication factor E1 and its auxiliary
protein, E2, which is also the viral transcription factor, together with the regulatory
proteins E6 and E7 are expressed early in infection. E2, E6, and E7 have each been
shown to control cellular gene expression (6). Viral gene expression required for
vegetative viral genome ampliﬁcation takes place in differentiating keratinocytes in the
middle to upper epithelial layers (9). At this stage, other viral regulatory proteins, E4 and
E5, that can regulate the host cell are expressed (6). Finally, L1 and L2 capsid protein
synthesis and virion formation take place in granular layer keratinocytes, and virions are
shed from the surface of the epithelium in dead squames (10). The epithelium presents
a barrier to the environment and to infectious agents (11). Differentiated keratinocytes
possess a dense ﬁlamentous network comprised of keratins and other molecules, such
as ﬁlaggrin. Moreover, keratinocytes have an important role in innate and adaptive
immunity, and cytokines, chemokines, and other immune signaling molecules released
by these cells are essential for epithelial homeostasis (12). HPVs have evolved to
modulate the epithelium to allow infection, virion formation, and egress (6), and many
means by which HPV evades the immune response have been documented (13).
Elucidating the interactions between HPV and the infected keratinocyte is key to
understanding the HPV life cycle and how persistent infection may facilitate the
development of cervical disease.
A number of previous studies have used a microarray approach to further our
understanding of the HPV infectious life cycle and cancer progression. The ﬁrst com-
pared gene expression in normal keratinocytes with that in HPV31-infected keratino-
cytes (14). Two subsequent studies examined gene expression changes during tumor
progression in HPV18-infected (15) or HPV33-infected (16) keratinocytes. A recent study
investigated undifferentiated keratinocytes containing HPV16 or HPV18 episomal ge-
nomes. However, no studies have analyzed how cellular gene expression is altered in
differentiating keratinocytes supporting the productive phase of the viral life cycle (17).
Here we used next-generation sequencing (RNA-Seq) to examine global changes in the
keratinocyte transcriptome due to epithelial differentiation and HPV infection. Our
study reveals that HPV infection induces massive changes in the transcriptome during
keratinocyte differentiation. In particular, changes led to the alteration of many genes
encoding the keratinocyte structural barrier and immune function. Key statistically
highly signiﬁcant changes in gene expression were conﬁrmed by reverse transcriptase
quantitative PCR (qRT-PCR) and Western blotting and were investigated in clinical
samples representing the cervical disease spectrum. These data can be used to under-
stand late events in the viral life cycle and the mechanisms behind cervical disease
progression.
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RESULTS
The HPV E2 transcription factor (18) and the viral oncoproteins E6 (19), E7 (20), and
E5 (21) can all play a role in controlling cellular gene expression, and HPV infection is
known to have a signiﬁcant effect on keratinocyte growth and differentiation (6). In
order to elucidate how cellular gene expression is altered during HPV infection, we
examined changes in the keratinocyte transcriptome during differentiation and HPV16
infection using normal, spontaneously immortalized keratinocytes (NIKS) and the same
cells stably transfected with HPV16 genomes (NIKS16). NIKS16 clone 2L maintains100
episomal HPV16 genomes per cell (if cultured at low passage [13]) and forms a
CIN1-like (low-grade cervical disease) stratiﬁed epithelium upon raft culture, suggesting
that these cells represent a transient HPV16 infection (22). We also examined a second
HPV16 infection model, W12 cells, which are HPV16-infected basal cervical epithelial
cells isolated from a patient with a low-grade cervical lesion (23). W12 clone 20863
(W12E) cells (if cultured at low passage [17]) also maintain 100 episomal HPV16
genomes (24). Both cell lines are capable of differentiation. We used the differentiation
protocol of Jeon et al. (24) in which cells are induced to differentiation by culturing to
high density in 1.2 mM Ca2. Differentiated NIKS16 and W12E cell populations ex-
pressed involucrin, loricrin, and keratin 10 proteins, key markers of keratinocyte differ-
entiation (Fig. 1A). NIKS16 cells (and W12 cells [25]) expressed viral late proteins E2, E4,
and L1 (Fig. 1A and B). A time course of NIKS and NIKS16 cell differentiation over a
13-day period is shown in Fig. 1C. As expected, NIKS cells (Fig. 1C, lanes 1 to 4)
expressed more involucrin over the time course than NIKS16 cells (Fig. 1C, lanes 5 to 8)
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FIG 1 Characterization of the HPV16 life cycle in NIKS16 and W12 cells. (A) Expression levels of keratinocyte protein differentiation markers and
viral L1 protein in undifferentiated (U  monolayer culture for 5 days) and differentiated (D  monolayer culture for 13 days) W12 and NIKS16
cells. GAPDH is shown as a loading control. (B) Expression levels of viral E2 and E4 proteins at 8 (mid-differentiation phase) and 13 (differentiated)
days of a time course of NIKS16 differentiation in monolayer culture. (C) Time course of involucrin protein expression over a 13-day differentiation
period (monolayer cells are mostly undifferentiated after 5 days of culture and fully differentiated after 13 days of culture) for NIKS and
NIKS16 cells. invol, involucrin. (D) Absolute quantiﬁcation by qPCR of L1 gene copies, as a measure of viral genomes, in differentiated W12
and NIKS16 cells. (E) Viral late mRNA levels quantiﬁed by detecting L1-containing mRNAs by qRT-PCR in undifferentiated and differentiated
W12 and NIKS16 cells. Invol, involucrin; K10, keratin 10.
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because HPV infection impairs epithelial differentiation (6). Absolute quantiﬁcation of
viral genome copies by PCR showed that differentiated W12 cells had an average of
15,250 genome copies, while there was an average of 9,937 copies of NIKS16 cells (Fig.
1D). Viral late mRNA levels, as measured by L1 open reading frame detection, the
common reading frame in all late mRNAs, were increased 16.1-fold in W12 cells and
12.6-fold in NIKS16 cells upon differentiation (Fig. 1E). These data indicate that NIKS16
and W12 cells can be differentiated in monolayer cultures.
Global changes in the transcriptome of HPV16-infected keratinocytes. RNA-Seq
was carried out using RNA prepared from undifferentiated and differentiated NIKS and
NIKS16 populations. Comparing undifferentiated with differentiated uninfected NIKS,
809 mRNAs were upregulated while 422 mRNAs were downregulated (Fig. 2A). In
contrast, in a comparison of undifferentiated to differentiated HPV16-infected NIKS16
cells, 2,041 genes were upregulated while 2,052 genes were downregulated (Fig. 2B).
Because NIKS16 cells are derived directly from NIKS (22) and were differentiated using
the same protocol, the 2,862 additional changes observed upon differentiation of
HPV16-positive keratinocytes are likely attributable to HPV infection. A number of gene
expression changes similar to that for NIKS16 cells was observed between undifferen-
tiated and differentiated W12E cells (data not shown). There is no HPV-negative
equivalent to W12 cells, but we examined the RNA-Seq changes in the transcriptome
of differentiated W12 cells compared to NIKS cells and the RNA-Seq changes in NIKS16
cells compared to the parent NIKS cells. Despite the fact that these cells are of different
origins, i.e., W12 is a female HPV-immortalized mucosal epithelial cell line and NIKS is
a spontaneously male cutaneous epithelial cell line, there was a 41% overlap in
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FIG 2 HPV16 infection induces massive changes in the keratinocyte transcriptome. (A) mRNA numbers expressed versus the level of expression
of each individual mRNA in undifferentiated (U) versus differentiated (D) NIKS (HPV-negative) cells. (B) mRNA numbers expressed versus the level
of expression of each individual mRNA in undifferentiated (U) versus differentiated (D) NIKS16 (HPV-positive) cells. (C) Venn diagram showing the
percentage identity between upregulated genes of NIKS and NIKS16 cells and those of NIKS and W12 cells. (D) Venn diagram showing the
percentage identity between downregulated genes of NIKS and NIKS16 cells and those of NIKS and W12 cells. Identity was determined using
the GFOLD tool to calculate the differential fold changes of the two comparisons.
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upregulated genes (Fig. 2C) and a 38% overlap in downregulated genes (Fig. 2D). These
data suggest that the effects of HPV infection and the differentiation process are
somewhat similar for both cell types.
HPV16 infection abrogates differentiation and epithelial barrier formation. We
are interested in elucidating the link between keratinocyte differentiation and late
events during HPV replication. Therefore, we compared the transcriptomes of differ-
entiated NIKS and NIKS16 cells. Three replicate, single-end sequencing experiments
were carried out, and changes that gave a P value of0.05 across three replicates were
discarded to achieve signiﬁcance. Table S1 in the supplemental material lists the top
966 changes in gene expression (P  0.05, log2  1.8, 3.5-fold change). There were 670
downregulated genes, while 296 were upregulated, with a range of 184-fold down-
regulated to 87-fold upregulated. The data in Fig. 3 show the mean of the results of
three separate RNA-Seq experiments. As expected, key epithelial differentiation mark-
ers were downregulated in NIKS16 cells (Fig. 3A). Suprabasal layer keratins were also
downregulated. Keratin 12, which is usually expressed only in the corneal epithelium
(26), was the only keratin whose levels were increased in NIKS16 cells (Fig. 3B).
Expression of cell junction proteins that are key to epithelial barrier function was
signiﬁcantly altered. Desmosome cell-cell junction proteins required for cell adhesion
(Fig. 3C) (27), and gap junction connexin (Cx) proteins 26, 30, and 32, which allow
transfer of small molecules between differentiating epithelial cells (28), were down-
regulated (Fig. 3D). Claudin proteins control tight junctions, and CLDN3, -10, and -22
were upregulated while CLDN11 and -17 were downregulated (Fig. 3E). Claudin up-
regulation can still have a negative impact on the function of tight junctions in a
phenomenon referred to as “leaky claudins” (29). Several adherens junction-associated
cadherins (27) were also downregulated (Fig. 3F). Small proline-rich repeat protein
(SPRR) family members that contribute to barrier formation by forming the corniﬁed
layer in differentiated epithelial cells (30) were downregulated (Fig. 3G). The calcium
gradient in the epithelium is altered upon loss of barrier formation (31), and levels of
RNAs encoding a range of calcium ion-binding proteins (e.g., S100A8/A9 calgranulin
complex, DSG1, matrix Gla protein [MGP], and calcium/calmodulin kinase 2B [CAMK2B])
were reduced (data not shown). Taken together, the data suggest that HPV infection
inhibits epithelial barrier formation and epithelial integrity.
The epithelial barrier also involves immune signaling, and signiﬁcant changes in
expression of many genes whose products are involved in intrinsic and innate immu-
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FIG 3 Keratinocyte differentiation and epithelial barrier function is altered by HPV infection. Signiﬁcant changes in expression (log2 1.8; 3.5-fold) of proteins
involved in keratinocyte differentiation and epithelial barrier function comparing HPV16-infected, differentiated NIKS keratinocytes to uninfected, differentiated
NIKS keratinocytes. These are mean values from three separate RNA-Seq experiments. (A) Markers of differentiation (ﬁlaggrin, loricrin, involucrin, and
transglutaminase [TGM1]); (B) keratins (K); (C) desomosomal proteins, desmogleins (DSG) 1 and 4, and desmocoilin (DSC); (D) gap junction proteins, connexins
(Cx) 26, 30.2, and 32; (E) claudins; (F) cadherins; (G) small proline-rich proteins (SPRRs).
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nity were also observed (Table 1). Previously, a microarray study revealed that HR-HPV
repressed activation of the immune response in undifferentiated epithelial cells
through interleukin 1 (IL-1). Similarly, in HPV-infected differentiated cells, we found
that IL1B gene expression was downregulated. IL1A was also downregulated, as were
IL32G and IL36B, which activate keratinocyte immune functions. The Langerhans cell
chemoattractant CCL20 was downregulated in the presence of HPV16. However, CCL28
that controls T-cell homing in mucosal epithelia, E6/E7-regulated CXCL12, and CX3CL1
were all upregulated. The type I interferon (IFN) regulator, IRF1, and the epithelial IFN-
were upregulated, an unexpected ﬁnding since HPV E6 and E7 have been shown to
inhibit their expression (32–34). We found a 6-fold downregulation of the viral DNA
pattern recognition receptor TLR7, which is expressed speciﬁcally in differentiated
keratinocytes (35), together with upregulation of viral restriction factors APOBEC3B,
IFIT1, -2, -3, and -5, CD74, OASL, and RTP4 (Table 1). These data indicate that the
keratinocyte-mediated immune response is under the control of HPV16 in the upper
epithelial layers and that there are signiﬁcant differences to HPV regulation of immune
signaling between differentiated and basal epithelial cells (17).
Cellular networks involved in the immune response and keratinocyte structure
and metabolism are altered by HPV16 infection. Following adjustment of the data
set to exclude any changes where the triplicate values gave a P value of 0.05, gene
ontology network pathway analysis of the top 1,000 up- or downregulated genes was
carried out. Analysis revealed distinct gene classes whose expression was altered by
HPV16 infection (Fig. 4). Response to type I interferon was upregulated, but cytokine
and chemokine expression was repressed. Cell matrix adhesion was upregulated, while
cell-cell adhesion was downregulated (reported by the Cytoscape program as negative
regulation of upregulated leukocyte genes) (Fig. 4A). Other signiﬁcantly downregulated
pathways included keratinization, arachidonic acid metabolism, reactive oxygen
and nitric oxide biosynthesis, vascular endothelial growth factor (VEGF), and tem-
perature homeostasis (Fig. 4B). Network analysis indicated that pathways related to
the type I interferon response were strongly connected (Fig. 4C), while downregu-
lated genes were associated through cytokine/chemokine/VEGF pathways (Fig. 4D).
A log2 change value of 2.5 was chosen to construct a wider pathway linkage
diagram. IRF1 and KDR genes were major HPV-upregulated genes encoding hub
proteins that connected a number of cell growth and apoptosis signaling pathways.
TABLE 1 Changes in expression of immune regulatory molecules and viral restriction
factors
Gene Categorya
Negative fold
change
Positive fold
change
TLR7 PRR 6-fold
NLRP3 Inﬂammasome component 7-fold
IL1A Cytokine 7-fold
IL1B Cytokine 4-fold
IL32G Cytokine 17-fold
IL36B Cytokine 6-fold
CCL20 Chemokine 7-fold
CCL28 Chemokine 5-fold
CXCL12 Chemokine 4-fold
CX3CL1 Chemokine 32-fold
APOBEC3C Restriction factor 4-fold
IFIT1 Restriction factor 6-fold
IFIT2 Restriction factor 7-fold
IFIT3 Restriction factor 7-fold
IFIT5 Restriction factor 4-fold
CD74 Restriction factor 4-fold
OASL Restriction factor 4-fold
RTP4 Restriction factor 13-fold
IRF1 IFN regulatory transcription factor 4-fold
IFN Interferon kappa 8-fold
aPRR, pattern recognition receptor; IFN, interferon.
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IL-1 and REL, an NF-B family transcriptional coactivator, linked HPV-downregulated
cytokine and VEGF (Fig. 5).
Veriﬁcation of gene expression changes due to HPV16 infection. Six genes from
among those with the statistically most highly signiﬁcant changes in expression (Table
2) (adjusted P [Padj] values are shown where a P of 0.05 in the triplicate data set is given
the value of 1) were selected for further study (negative, DSG1, SERPINB3, and KRT10;
positive, VTCN1, KDR, and AZGP1). Although IL1B had a Padj of 1 (actual P value  0.05),
it was also included because expression of this important gene was found to be a key
gene network hub in both undifferentiated (17) and differentiated HPV-infected cells
(Fig. 5). These genes all encode proteins with known metabolic or immune/inﬂamma-
tory roles in the normal epithelium. KRT10 is a differentiation-speciﬁc keratinocyte
ﬁlament protein. DSG1 is a calcium-binding desmosome regulator. KDR (vascular
endothelial growth factor receptor 2 [VEGFR-2]) has an autocrine function in cell
proliferation, adhesion, and migration (36). IL-1 “node” cytokine activates adaptive
immunity. VTCN1 is a T-cell activation inhibitor. SERPINB3 controls epithelial inﬂamma-
tory responses, and AZGP1 is induced by IFN- in keratinocytes (37). mRNA expression
in NIKS versus NIK16 cells and W12 cells was validated by qRT-PCR (Table 2).
Up-regulated genes
+ve regulation of cell matrix adhesion
serine-type endopeptidase inhibitor activity
-ve regulation of leukocyte cell-cell adhesion
response to type I interferon
serine-type endopeptidase inhibitor activity
arachidonic acid metabolic process
keratinization
reactive oxygen species biosynthetic process
vascular endothelial growth factor production
interleukin-2 production
temperature homeostasis
nitric oxide biosynthetic process
regulation of VEGF production
regulation of chemokine production
Down-regulated genes
% Genes/Term
% Genes/Term
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B
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Down-regulated genes
FIG 4 ClueGO analysis of signiﬁcantly up- and downregulated genes in HPV16-infected, differentiated NIKS keratinocytes compared to uninfected,
differentiated NIKS keratinocytes. We used CluePedia, which extends ClueGO (71) functionality down to genes and visualizes the statistical dependencies
(correlation) for markers of interest from the experimental data. (A) Gene ontology (GO) pathway terms speciﬁc for upregulated genes. (B) GO pathway terms
speciﬁc for downregulated genes. The bars represent the numbers of genes associated with the terms on the left. The percentage of altered genes is shown
above each bar. Red asterisks refer to signiﬁcance. (C) Functionally grouped network for upregulated genes. (D) Functionally grouped networks for
downregulated genes. Only the label of the most signiﬁcant term per group is shown. The size of the nodes reﬂects the degree of enrichment of the terms.
The network was automatically laid out using the organic layout algorithm in Cytoscape. Only functional groups represented by their most signiﬁcant term
were visualized in the network. Padj changes of 0.05 were analyzed.
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Protein levels encoded by these mRNAs were examined in undifferentiated and
differentiated NIKS, NIKS16, and W12 cells (Fig. 6). Levels of AZGP1, KDR, DSG1, KRT10,
and involucrin increased upon NIKS16 and W12 cell differentiation, while SERPINB3
levels decreased and VTCN1 levels did not change. There were higher levels of VTCN1,
AZGP1, and KDR in NIKS16 cells than in differentiated NIKS cells, but KRT10 and DSG1
levels were much lower in differentiated NIKS16 cells than in NIKS cells, as expected.
SERPINB3 levels were greatly reduced following differentiation of NIKS16, but not NIKS,
cells. There is no HPV-negative W12 cell equivalent to NIKS cells, so it is not possible to
be sure if the changes in protein expression in W12 cells upon differentiation are due
to HPV infection. These data conﬁrm that selected keratinocyte transcriptomic changes
due to HPV16 infection are reﬂected in protein levels.
HPV16 infection-regulated mRNAs as biomarkers of cervical disease. It could be
argued that the NIKS16 model of the HPV16 life cycle may not directly relate to cervical
HPV infection because NIKS16 cells are foreskin, not cervical, keratinocytes, However,
NIKS16 cells appeared to represent a low-grade cervical lesion when grown in raft
culture (22), and there is a similar organization of the HPV life cycle at different
anatomical sites (38). HPV16-associated gene expression changes in keratinocytes could
be related to the productive life cycle but could equally be associated with cervical
disease progression. Therefore, to test whether any of the HPV-related changes in
keratinocyte gene expression that we detected could have potential as HPV-associated
cervical disease biomarkers, we quantiﬁed levels of expression of three upregulated
and three downregulated genes (encoding two regulators of the inﬂammatory re-
sponse [IL-1, SERPINB3], two proteins involved in cell signaling [KDR, VTCN1], and two
involved in barrier function [KRT10, DSG]) by qRT-PCR in liquid-based cytology (LBC;
Pap smear) samples. Apart from choice due to gene function, IL-1 RNA was chosen for
analysis because it encoded a hub in the interactome (Fig. 5), VTCN1 and DSG1 were
chosen as representatives of very highly signiﬁcantly altered RNAs, KRT10 was chosen
as a differentiation marker, KDR was chosen as an RNA potentially involved in cancer
formation, and SERPINB3 was chosen because it was an early identiﬁed cervical cancer
marker (39). Due to lack of mRNA, we were unable to test AZGP1. A control cDNA from
differentiated W12E cervical keratinocytes was included in each qRT-PCR plate as a
standard, and absolute levels of RNA in the LBC samples (normalized against GAPDH
[glyceraldehyde-3-phosphate dehydrogenase]) were calculated using the Pfafﬂ stan-
dard curve method (40, 41). KRT17 was analyzed as a known biomarker of cervical
disease progression (42). Figure 7 shows the mean and range of values for each mRNA
in 7 samples of no detectable disease (NDD), 10 samples of low-grade cervical lesions
FIG 5 Interactome of negatively and positively changed genes comparing differentiated NIKS with differentiated
NIKS16 cells. Interactome of genes linked through statistical correlation of upregulated (A) and downregulated (B)
genes from the experimental data (P  0.05). Gray lettering and diamonds indicate genes identiﬁed in the
RNA-Seq data set. Black lettering indicates linked genes. Nodes for genes identiﬁed in the data set are indicated
by black box outlines. Dots/lines surrounding nodes indicate the numbers of linked pathways. The pathway
analysis was produced using CluePedia (http://apps.cytoscape.org/apps/cluepedia).
TABLE 2 RNA-Seq expression changes in mRNAs of statistical signiﬁcance (P 0.025) veriﬁed by qRT-PCR
Gene Padj
NIKS16/NIKS fold
change by RNA-Seq
NIKS16/NIKS fold
change by qPCR
W12/NIKS fold
change qPCR Gene product/function
DSG1 2.05  105 19.95 4.20 3.52 Desmoglein 1: calcium-binding desmosome regulator
IL1B 1 8.68 5.65 7.73 Interleukin 1: inﬂammatory response regulator
SERPINB3 0.008 8.40 4.28 4.410 Intracellular protease inhibitor, inhibits active
inﬂammatory response
KRT10 0.021 7.07 10.26 3.70 Keratin 10: epithelial cytoﬁlament
KDR 0.025 10.21 10.10 4.30 VEGFR-2, tyrosine kinase receptor
VTCN1 1.4  109 46.12 8.94 10.56 V-set domain-containing T-cell activation inhibitor-1
AZGP1 2.05  105 12.64 7.49 8.31 Zinc alpha-2 glycoprotein: lipid metabolism
GAPDH 1 1 1 Glyceraldehyde-3-phosphate dehydrogenase (control)
Beta-actin 1 1 1 Actin (control)
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(CIN1), and 10 samples of high-grade cervical lesions (CIN3). Although we analyzed 10
samples graded as NDD, once HPV typing status was revealed, 3 of these 10 were HPV
positive. We decided to exclude these from the analysis in order to compare HPV-
negative and HPV-positive clinical samples. KRT10 mRNA levels were very low, making
analysis of signiﬁcance difﬁcult, and there was high variability in levels of IL-1 and
VTCN1. However, very high levels of IL-1 mRNA were detected in all patient samples,
regardless of disease stage. DSG1 was signiﬁcantly increased between no detectable
disease (NDD) samples and low-grade disease samples but signiﬁcantly decreased
between low-grade and high-grade disease samples. KDR and SERPINB3 levels were
signiﬁcantly upregulated between low-grade and high-grade disease samples, similar
to the positive control, KRT17. These data suggest that RNA-Seq analysis has the
potential to uncover novel biomarkers of cervical disease.
DISCUSSION
The aim of our work was to examine how human papillomavirus replication is linked
to keratinocyte differentiation. In particular, we were interested in how differentiating
keratinocytes respond to HPV infection during the late, productive phase of the viral life
cycle. As a model to compare HPV-negative to HPV-positive keratinocytes, we used
NIKS and NIKS16 cells. NIKS are spontaneously immortalized neonatal foreskin kerati-
nocytes that have no alterations in differentiation or apoptosis (43). NIKS16 cells were
derived directly from NIKS cells by stable transfection of the HPV16 genome isolated
from W12 cells (22). We have shown that the NIKS16 cells adequately support the
infectious viral life cycle (as previously reported [22]) because several key markers of
keratinocyte differentiation and viral life cycle completion, i.e., viral genome ampliﬁca-
tion, viral late mRNA induction, and capsid protein production, were detected. More-
over, because there was repression of VEGF pathways, reduced expression of HOX and
MMP proteins, and no general upregulation of EMT markers, these cells are likely not
undergoing tumor progression. Because NIKS cells are foreskin keratinocytes, they will
likely have a number of differences in their gene expression proﬁle compared to that
of cervical keratinocytes. We did not have access to spontaneously immortalized
HPV-negative cervical keratinocytes, but we compared changes in W12 gene expres-
sion with NIKS cells. There was around 40% identity in the up- and downregulated
genes between NIKS16 and W12 cells. W12 cells are naturally infected, female, mucosal
epithelial cells, while NIKS16 cells are male cutaneous epithelial cells and spontaneously
KRT10
GAPDH
SERPINB3
DSG1
Invol
HPV down-regulated
genes
B
NIKS NIKS16
U    D    U    D       U     D 
GAPDH
VTCN1
KDR
AZGP1
A HPV up-regulated
genes
NIKS NIKS16
U    D    U    D      U     D kDa kDa
38
38
97
59
45
114
34
31
152
W12 W12
FIG 6 Western blot analysis of protein levels encoded by selected, signiﬁcantly altered mRNAs (Table 2).
Protein extracts were prepared from undifferentiated (U) and differentiated (D) HPV-negative NIKS and
HPV16-positive NIKS16 and W12 cell populations. Much greater levels of involucrin (invol) were detected
in the differentiated than in the undifferentiated cell populations, indicating that differentiation was
achieved. GAPDH was used as a protein loading control. (A) Protein levels corresponding to signiﬁcantly
upregulated mRNAs; (B) protein levels corresponding to signiﬁcantly downregulated mRNAs.
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immortalized, and these signiﬁcant differences likely account for the remaining 60% of
nonoverlapping genes. Therefore, NIKS16 is potentially a more robust model for
HPV16-associated penile lesions than cervical lesions, and it will be interesting in the
future to compare these data sets with similar sets from differentiated uninfected and
infected cervical keratinocytes. Three-dimensional raft culture would undoubtedly
provide a superior approach for examining keratinocyte differentiation and HPV infec-
tion. However, for analysis of late events in the viral life cycle in differentiated kerati-
nocytes, this is technically challenging and difﬁcult to reproduce, because RNA isolation
from multiple, microdissected, upper epithelial layer sections would be required for
triplicate RNA-Seq experiments. Our current data set should provide an important basis
for subsequent analysis of raft culture models.
Many transcriptomic studies have analyzed cellular changes during HPV-associated
tumor progression or due to overexpression of viral proteins (14, 15, 18, 21, 44–51). Of
the microarray studies investigating changes due to HPV infection, as opposed to
tumorigenesis, one compared expression of HPV31-positive and -negative cervical
keratinocytes (14), a second examined HPV33-negative and -positive vaginal keratino-
cytes (16), while another compared undifferentiated anogenital keratinocytes with or
without episomal HPV16 and HPV18 genomes (17). All of these studies focused on the
FIG 7 Expression levels of selected, signiﬁcantly altered mRNAs in different grades of HPV-associated preneoplastic cervical disease. mRNA expression levels were
calculated from qRT-PCR data using GAPDH and beta-actin as the internal controls and expressed relative to levels in a single sample of differentiated, HPV16-positive
W12 cell RNA that was included in every PCR run. NDD, no detectable disease/borderline, all HPV negative; low-grade disease, cervical intraepithelial neoplasia 1 (CIN1),
all HPV positive; high-grade disease, cervical intraepithelial neoplasia 1 (CIN3), all HPV positive.
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effect of HPV on basal keratinocytes, the site of viral entry, and initial replication. No
studies to date have examined keratinocyte responses to late events in the viral
replication cycle. Moreover, the previous studies used microarray analysis, which does
not provide the unparalleled depth of information available from RNA-Seq. To our
knowledge, this is the ﬁrst report comparing the transcriptomes of uninfected and
HPV-infected differentiated keratinocytes using RNA-Seq. HPV infection induced mas-
sive changes (2,862 additional expression changes compared to the transcriptome of
HPV-negative NIKS cells) in the keratinocyte transcriptome. Desmosomes, adherens,
and tight and gap junction classes were all downregulated in the presence of HPV16,
likely due to HPV16 E6/E7 reactivation of the cell cycle and decreased keratinocyte
differentiation (52), as has been reported previously (17). Together with high-level
downregulation of SPRRs, altered arachidonic acid metabolism, and changes in mucins,
one can conclude that HR-HPV infection results in a broad abrogation of epithelial
barrier function and epithelial integrity. Reduced barrier function could result in
increased fragility of cells in the upper epithelial layers to facilitate viral egress.
Keratinocytes are key players in the immune response, and they produce a panoply
of molecules involved in host defense against pathogens. In differentiated NIKS16
keratinocytes, HPV infection altered gene expression related to innate immunity,
including reduced expression of the TLR7, IL1A, IL1B, NLRP3, IL36B, and IL32G genes.
TLR7, a pattern recognition receptor for viral nucleic acids, is upregulated upon
keratinocyte differentiation (35) and activates proinﬂammatory cytokines and other
molecules involved in the adaptive immune response. There was a 6-fold downregu-
lation of TLR7 in the presence of HPV16, suggesting that the virus represses pattern
recognition during vegetative viral genome ampliﬁcation, but by a different mecha-
nism than that used in undifferentiated keratinocytes where infection suppresses TLR9
(17). There was a corresponding reduction in NF-B-regulated CCL20, known to be
regulated by HPV E7 (53) and required to recruit Langerhans cells. Indeed, NF-B
signaling was affected, and the NF-B family member REL was a major HPV-regulated
control node in the pathway analysis of negatively regulated genes (Fig. 5). Surprisingly,
we discovered that the epithelium-speciﬁc IFN-, and IRF1 that controls type I IFNs, was
upregulated by HPV16 in differentiated keratinocytes. Previously, HPV16 E7 or HPV38
E6/E7 were shown to inhibit IRF1 expression (32, 33), while HPV16 E6 was shown to
repress IFN- transcription through promoter methylation (54). However, these studies
used overexpression of the viral oncoproteins. The levels of E6 or E7 proteins may be
much lower in differentiated keratinocytes than in the undifferentiated epithelial cells
or cervical cancer cells used in these studies. In contrast to E6 and E7, E5 can stimulate
IRF1 expression in HaCaT cells (55). Changes due to expression of the entire virus
genome may be more complex and quite different from that seen with the expression
of individual viral proteins. Upregulation of interferon-induced protein with tertatrico-
peptide repeats (IFITs) corresponded with the observed activation of the type I inter-
feron response. Only IFIT1 has been shown to inhibit HPV replication (56, 57); therefore,
the roles of other IFITs in inhibiting HPV infection remain to be determined. APOBEC3B
was upregulated; however, we found no changes in expression of APOBEC3A, a known
HPV restriction factor, but its expression may be differentially regulated only in less
differentiated keratinocytes (58). The observed upregulation of CXCR6 and CXCL12 is in
agreement with CXCL12 detection in HPV-induced lesions and its role in the productive
HPV life cycle (59). We also detected changes in some SERPINs (e.g., SERPINB3) that are
involved in the inﬂammatory/immune response (60). We did not detect changes in
STAT1, which has been shown to be controlled by E6 and E7 (61). It is possible that it
undergoes changes of less than the cutoff of 3.5-fold considered here. However,
STAT1 controls IRF1 expression, which was upregulated 4-fold, and STAT1 was a central
node connecting gene pathways regulated by HPV16 (Fig. S1). Of course, because we
used an immortal cell line, immortalization could account for some of the changes we
observed. It will be important to analyze innate immune regulators in differentiated
primary cervical keratinocytes in future studies. Our data reveal that HPV suppression
of intrinsic and innate immunity takes place not only in infected basal epithelial cells
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(17) but also in keratinocytes harboring late events in the HPV life cycle and that a
differentiation stage-speciﬁc set of events may be relevant to this life cycle stage. The
stimulation of the IFN response and viral restriction factors in differentiated HPV-
infected cells requires further study. Production of progeny viral genomes and virions
may stimulate the IFN response and lead to apoptosis, and this could aid release and
dissemination of virus particles.
The E5, E6, E7, and E2 proteins of HPV16 are known to control cellular gene
expression. E6 and E7 control keratinocyte cell cycle and apoptosis and abrogate
differentiation. Many of the changes in gene expression that we have observed can be
attributed to these functions of the viral oncoproteins. These changes are clearly
important for the replicative life cycle of HPV16 but could also contribute to HPV
persistence and development of neoplasia (6). Similar to data from one overexpression
study of HPV16 E6 in human foreskin keratinocytes (50), the differentiation marker
involucrin, vimentin, which is expressed upon epithelial stress, and signal transduction
proteins MEST and H19 were upregulated in our analysis. However, we detected none
of the other changes affecting cell cycle, proliferation, DNA damage, metabolism, or
signaling that have previously been reported (50). We discovered only seven genes
(those encoding semaphorin 5A [SEMA5A], CXCL1, ENTPOT, follistatir [FST], cytochrome
P450 [CYP] 24A1, pleckstrin homology-like domain A1 [PHLDA1], and ribosomal protein
S27-like [RPS27L]) out of a total of 99 altered in another study using small interfering
RNA (siRNA) depletion of E6 in HPV-positive tumor cells (47). Compared to a study of
W12 cells with integrated HPV16 genomes expressing different levels of E6 and E7, we
detected genes encoding E6-regulated loricrin (LOR) and cytochrome P450 (CYP) 1B1
and E7-regulated FABP4, SERPINA3, and SLURP1 out of the top 20 genes upregulated
by each protein (62). Only 1 out of 12 master regulators of E6 or E7 function deﬁned by
Smith et al. (62) was in common with our study. This was downregulation of PRDM1
(BLIMP-1), which acts as a repressor of IFN- gene expression. E5 overexpression in
HaCaT keratinocytes yielded 61 mRNAs with signiﬁcant changes (21), but only two of
these (keratin 8 and MMP16 mRNAs) were in common with our RNA-Seq data. In a
microarray study of E2 overexpression in U2OS cancer cells where 74 genes were found
to be regulated, only 3 of these (those encoding heterotrimeric G-complex protein 11
[GNG11] involved in cell signaling, histamine N-methyltransferase [HNMT] involved in
methylation of histamine, and SERPINA3, which is upregulated in response to de-
creased transglutaminase activity) were altered in our study. The increased viral onco-
protein expression levels in HPV-positive cancer cells, or in cells overexpressing viral
proteins, compared to the model we have used, i.e., keratinocytes supporting expres-
sion of all viral proteins from the intact HPV16 genome where expression levels are
much lower (3), could explain the fact that we did not detect many of these changes.
Moreover, we have only considered expression changes of 3.5-fold, while these other
studies considered 2-fold changes. RNA-Seq analysis of the W12 tumor progression
series (63) would help to delineate infection- versus cancer-related changes.
Liquid-based cytology samples (LBCs; Pap smear samples) contain cells scraped from
the top of the cervical epithelium and thus contain HPV-infected differentiated kerati-
nocytes. Therefore, some of the mRNA changes we have detailed could be biomarkers
of cervical disease. Very high levels of IL-1mRNA were detected in all patient samples,
regardless of disease stage, likely due to inﬂammation commonly observed in the
diseased cervix. Statistically signiﬁcant changes in KDR and SERPINB3 expression, like
the known biomarker KRT17, indicate their potential in identifying high-grade cervical
disease. DSG1 was signiﬁcantly increased between no-detectable-disease (NDD) sam-
ples and low-grade disease samples but signiﬁcantly decreased between low-grade and
high-grade disease samples. This is in contrast to the clear downregulation of DSG1
expression due to HPV16 infection of NIKS and suggests either that NIKS16 cells may
not represent a low-grade HPV16-positive lesion or that the levels of DSG1 in cervical
keratinocytes are very different from those in foreskin keratinocytes.
In conclusion, we report for the ﬁrst time RNA-Seq analysis of changes in the
keratinocyte transcriptome caused by HR-HPV infection. Infection caused massive
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changes in epithelial gene expression. These changes showed mainly a proﬁle expected
of viral infection rather than tumor progression. The large data set we have developed
opens up the possibility of a deeper understanding of late events in the HPV replication
cycle in response to keratinocyte differentiation. As well as shedding light on late
events during the HPV16 life cycle, the RNA-Seq data might uncover potential bio-
markers of HPV-associated anogenital disease progression. From our analysis, DSG1,
KDR, and SERPINB3 expression may have potential as robust markers that can risk-
stratify cervical disease, i.e., identify cervical disease cases that have a high probability
of regression, and this would be of signiﬁcant clinical value. However, further longitu-
dinal studies in which biomarker status is linked to clinical outcomes are required to
validate any biomarkers for such an application.
MATERIALS AND METHODS
Clinical sample panel underlying pathology and HPV status. Anonymized, cervical liquid-based
cytology samples were obtained from the Scottish National HPV Archive, which holds Generic Scotland
A Research Ethics Committee approval for Research Tissue Banks (REC Ref 11/AL/0174) for provision of
samples for HPV-related research after approval from an independent steering committee. The Scottish
HPV Archive also comes under the auspices of the NHS Lothian Bioresource. The panel comprised
HPV-negative/cytology-negative (no disease, n  7) samples with low-grade cytological abnormalities
with histological conﬁrmation of cervical intraepithelial neoplasia 1 (CIN1) (low-grade disease, n  10)
and samples with high-grade cytological abnormalities with histological conﬁrmation of CIN2 or worse,
including cancer (high-grade disease, n  10). Cytology grades were reported according to the British
Society for Clinical Cytopathology (BSCC) classiﬁcation (64–66). HPV testing was performed by the
Optiplex HPV genotyping assay (Diamex, Heidelberg, Germany) according to the manufacturer’s instruc-
tions. The Optiplex test is a PCR-based assay which uses a Luminex platform for the detection of 24
individual HPV types, including all types established as high risk according to the International Agency
on Research on Cancer. For the purposes of this panel, the main function of the genotyping was for the
annotation of no-disease “controls.” Women with negative cytology and HPV-negative status are at a
very low risk of underlying disease (negative predictive value for a high-grade lesion of 95% [67]) All
experiments were performed in compliance with relevant laws and institutional guidelines and in
accordance with the ethical standards of the Declaration of Helsinki.
Cell lines. W12E (24), NIKS (43), and NIKS16 (22) cells were cocultured in E-medium with mitomycin
C-treated J2 3T3 ﬁbroblast feeder cells as previously described (24). Differentiation was induced by
growth to high density in 1.2 mM Ca2 (24). 3T3 cells were grown in Dulbecco’s modiﬁed Eagle medium
(DMEM) with 10% donor calf serum. Prior to harvesting, 3T3 cells were removed by trypsinization, and
cell layers were washed twice with phosphate-buffered saline (PBS). All cells were maintained under
humidiﬁed 5% CO2–95% air at 37°C.
RNA isolation. (i) Cell lines. Protocols followed the manufacturer’s instructions. Total RNA was
prepared using a Qiagen RNeasy kit. RNA was quantiﬁed and purity assessed by measuring the ratio
of the absorbance at 260 to that at 280 nm using a Nanodrop ND-1000 spectrophotometer (Thermo-
Scientiﬁc). Polyadenylated RNA was prepared using an oligo(dT)-based mRNA extraction kit (Oligotex,
Qiagen).
(ii) Clinical samples. LBC cells in 4 ml of PreservCyt collection medium (Cytyc Corporation) were
pelleted by centrifugation in a Beckman GPR benchtop centrifuge at 1,500 g for 10 min. The cell pellet
was washed with sterile PBS. RNA extraction was carried out using an RNeasy miRNA preparation kit
(Qiagen). RNA was quantiﬁed and purity was assessed by measuring the ratio of the absorbance at 260
to that at 280 nm using a Nanodrop ND-1000 spectrophotometer.
qRT-PCR. For cell line and clinical samples, DNA was removed using Maxima DNase, and treated RNA
was reverse transcribed using a Maxima ﬁrst-strand cDNA synthesis kit according to the manufacturer’s
instructions (ThermoScientiﬁc). Standard curves were generated as recommended (Applied Biosystems
instruction manual). Triplicate ampliﬁcation reactions containing 100 ng cDNA each were carried out.
GAPDH and -actin were used as the internal standard controls. Probes and primers were as follows:
GAPDH F, 5=-GAAGGTGAAGGTCGGAGT-3=; GAPDH R, 5=-GAAGATGGTGATGGGATTTC-3=; GAPDH probe,
5=-CAAGCTTCGTTCTCAGCC; KRT10F, 5=-TGGTTCTTGCCTCAGAAGAGCTGA-3=; KRT10 R, 5=-AGTACACGGT
GGTGTCTGTGTCAT-3=; KRT10 probe, TGTGTCCACTGGTGATGGGAATGTGG-3=; DSG1 F, 5=-ACGTTCACGAT
AACCGACCAGCAT-3=; DSG1 R, 5=-ATTCCATGCAAATCACGGCCAGAG-3=; DSG1 probe, 5=-AACGTGGTAGT
GACAGAGAGAGTGGT-3=; KDR F, 5=-TGGTTCTTGCCTCAGAAGAGCTGA-3=; KDR R, 5=-AGTACACGGTGGTGT
CTGTGTCAT-3=; KDR probe, 5=-TGGCATCTGAAAGCTCAAACCAGACA-3=; IL1B F, 5=-TCTGTACCTGTCCTGCG
TGTTGAA-3=; IL1B R, 5=-TGCTTGAGAGGTGCTGATGTACCA-3=; IL1B probe, 5=-CAAGCTGGAATTTGAGTCTG
CCCAGT-3=; VTCN1 F, 5=-CACCAGGATAACATCTCTCAGTGAA-3=; VTCN1 R, 5=-TGGCTTGCAGGGTAGAA
TGA-3=; VTCN1 probe, 5=-AAGCTGAAGATAATCCCATCAGGCAT-3=; SERPINB3 F, 5=-GCTGCCAAATGAAATC
GATGGTCTCC-3=; SERPINB3 R, 5=-TTCCCATGGTTCTCAACGTGTCCT-3=; SERPINB3 probe, 5=-AACTCGGTTC
AAAGTGGAAGAGAGCT-3=; KRT17 F, 5=-GATGCGTGACCAGTATGAGAAG-3=; KRT17 R, 5=-CGGTTCAGTTC
CTCTGTCTTG-3=; KRT17 probe, 5=-ATGGCAGAGAAGAACCGCAAGGAT-3=. Reaction mixtures (25 l)
contained 1 Mastermix (Stratagene), 900 nM primers, 100 nM probe, and 300 nM reference dye
(Stratagene). qRT-PCRs were performed and analyzed on an Applied Biosystems 7500 Fast System.
Graphing and statistical analyses were performed using GraphPad Prism 7. Statistical analysis (all three
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groups were compared to each other) was performed by the Kruskal-Wallis test, and data were analyzed
by one-way analysis of variance (ANOVA) with Tukey’s posttest. A signiﬁcance level at a P of 0.05 was
used.
Western blot analysis. Cells were lysed in 2 protein loading buffer (125 mM Tris [pH 6.8], 4% SDS,
20% glycerol, 10% mercaptoethanol, and 0.006% bromophenol blue with fresh protein inhibitor cocktail
[Roche, United Kingdom]). Protein extracts were passaged with a syringe through a 22-gauge needle 15
times and then sonicated in a Sonibath for three 30-s pulses to break up the DNA strands. The samples
were boiled at 100°C for 5 min before being loaded on a 12% Novex gel (Invitrogen) and electrophoresed
at 150 V for 1 h in 1 MES (morpholineethanesulfonic acid) buffer. Gels were transferred to a
nitrocellulose membrane using an iBlot transfer kit and iBlot gel transfer stacks (Invitrogen) per the
manufacturer’s instructions. Membranes were blocked in 5% milk powder in PBST (PBS-Tween 20) at
room temperature for at least 1 h. Membranes were washed three times in PBST for 5 min each and then
incubated with primary antibody. Mouse GAPDH (Meridian; 6C5), involucrin (Sigma; I9018), loricirn
(Abcam; ab85679), serpinB3 (Sigma; 2F5), and keratin 10 (Abcam; ab9026) monoclonal antibodies were
used at a dilution of 1:1,000. HPV16 E2 antibody (Santa Cruz; TVG261) was used at 1:500 dilution. HPV16
L1 antibody (Dako; K1H8) was used at a 1:400 dilution. HPV16 E4 antibody (gift of J. Doorbar, Cambridge,
United Kingdom; clone B11) was used at a dilution of 1:50. Rabbit DSG1 (Abcam; ab133662), VEGFR2
(KDR) (Abcam; ab39256), and AZGP1 (Invitrogen; PA5-44912) polyclonal antibodies were used at a
1:1,000 dilution. VTCN1 (Proteintech; 12080-1-AP) was used at a dilution of 1:500. The blots were
incubated in their respective antibodies for 1 h at room temperature or overnight at 4°C. After 1 h, the
blots were washed three times in PBST for 5 min. They were then placed in secondary antibody for 1 h
(horseradish peroxidase [HRP]-linked goat anti-mouse or goat anti-rabbit [Pierce] antibodies were used
at a 1:2,000 dilution). Blots were washed three times in PBST for 5 min before being incubated with ECL
Western blot substrate. The blots were exposed to X-ray ﬁlm (ThermoScientiﬁc) and processed in an
X-Omat processor.
Illumina sequencing. Integrity of RNAs was assessed using an Agilent 2100 Bioanalyzer. cDNA was
synthesized using reagents from the TruSeq RNA sample preparation kit (Illumina) according to the
manufacturer’s instructions. cDNA libraries were sequenced with a 73-base single-end read on an
Illumina Genome Analyzer IIx at the Glasgow Polyomics facility at the University of Glasgow.
Computational analysis. Data sets were cleaned of reads with runs of 12Ns. Alignment to the
human cDNA set (145,786 cDNAs—downloaded on 28 November 2011) was performed using Bowtie
version 0.12.7. Further alignment to an updated human cDNA set (180,654 cDNAs downloaded 30 April
2012) was carried out using BWA 0.7.12-r1039. DESeq implemented in BioConductor (68) was used to
select cellular genes whose expression was up- or downregulated by HPV in NIKS16 compared to NIKS
cells implemented in the R environment. The raw read counts were normalized using reads per kilobase
of transcript per million mapped reads (RPKM). DESeq uses a negative binomial error distribution to
model transcript abundance and determine the differential expression. The signiﬁcance of differential
expression was estimated for each gene and then corrected for multiple comparisons (Padj). The top
1,000 differentially expressed genes based on log-fold change (Log2FoldChange) of 1.8 (3.5-fold
change) are listed in Table S3 in the supplemental material.
Functional analysis of differentially expressed genes. GO (69) and KEGG (70) enrichment analyses
were performed using Cytoscape (http://cytoscape.org/) with ClueGO (version 2.3.2) (71). The statistical
test used for the enrichment was based on a two-sided hypergeometric option with a Bonferroni
step-down correction, a P value of less than 0.05, and a kappa score of 0.4.
Accession number(s). Samples have been submitted to SRA@ncbi.nih.gov under the following
Bioproject (GenBank) accession numbers: for the study, accession no. PRJNA379358 (SRP104232); for the
sample NIKS16_D11_Mar17, accession no. SRS2131727; for the experiment with differentiated NIKS16
cells, accession no. SRX2745325; and for the run with NIKS_HPV16_D11_Mar17.fq.gz, accession no.
SRR5457256. For the sample NIKS16_D5_Mar17, accession no. SRS2131728; for the experiment with
undifferentiated NIKS16 cells (SRX2745326); and for the run with NIKS_HPV16_D5_Mar17.fq.gz, accession
no. SRR5457258. For the sample NIKS_D11_Mar17, accession no. SRS2131729); for the experiment with
differentiated NIKS cells, accession no. SRX2745327; and for the run with NIKS_D11_Mar17.fq.gz, acces-
sion no. SRR5457259. For the sample NIKS_D5_Mar17, accession no. SRS2131730; for the experiment with
undifferentiated NIKS cells, accession no. SRX2745328; and for the run with NIKS_D5_Mar17.fq.gz,
accession no. SRR5457260.
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